Corinna Wehmeyer PhD, Dr. Katja Naie
Photo: Jaqueline Hirscher
Corinna Wehmeyer PhD
This year’s Avrion Mitchison Prize for the best research work in rheumatology is awarded to Corinna Wehmeyer. She will present her research on the occasion of the award ceremony on December 6, 2016.
Corinna Wehmeyer produced her award-winning work at the Institute of Experimental Musculoskeletal Medicine at the Münster University Hospital, where she worked as a researcher until May 2016 before moving to the University of Birmingham in September 2016. In her lecture, “Loss of Wnt inhibitor sclerostin promotes TNF-dependent inflammatory bone destruction,” Wehmeyer explains that sclerostin, known as a bone loss mediating molecule, also seems to have a protective role in TNF-mediated inflammatory diseases such as rheumatoid arthritis. Using sclerostin inhibitors to treat the bone loss increases the inflammation and aggravates disease progression. Unlike in the case of osteoporosis patients, caution should be taken when considering anti-sclerostin antibodies treatment in patients with rheumatoid arthritis or with chronic TNF-dependent comorbidities.Share this post
December 06, 2016, 5–7:30 p.m.
Avrion-Mitchison-Prize for Rheumatology 2016 and Albrecht Hasinger Lecture 2016
Foyer des Deutschen Rheuma-Forschungszentrums Berlin
Campus Charité Mitte | Charitéplatz 1 | 10117 Berlin
On December 6th, 2016 at 6.10 p.m. the Albrecht Hasinger Lecture is hold by Goldring, PhD Hospital for Special Surgery, NYC, USA on “The elusive search for a target in osteoarthritis therapy".Learn more
Corinna WehmeyerDownload File
Unter den Linden 32-34
Telefon: +49.30.20 62 29 62
Thursday to Monday: 1 pm - 7 pm
Saturday to Sunday: 11 am - 7 pm